M11.1

Clinical Causes: Genetic mutations passed down through families that affect cartilage metabolism Inherited predisposition leading to abnormal calcium pyrophosphate crystal formation Compromised cartilage structure that facilitates crystal deposition Potential environmental factors such as joint trauma or metabolic conditions that may exacerbate symptoms

Key Symptoms: Joint pain, especially in the knees, wrists, and hips Swelling and tenderness around affected joints Stiffness, particularly after periods of rest or inactivity Episodes of acute joint inflammation, resembling gout attacks Reduced joint mobility over time Possible presence of crystal deposits detectable via imaging tests

Diagnosis Path: Diagnosis of familial chondrocalcinosis involves a combination of clinical assessment and diagnostic procedures, including: - Reviewing family medical histories for similar symptoms or diagnoses - Physical exams to identify joint swelling, tenderness, or deformity - Imaging tests like X-rays to visualize calcification within the cartilage - Synovial fluid analysis from affected joints to detect calcium pyrophosphate crystals under a microscope - Blood tests to rule out other causes of joint symptoms and assess overall metabolic health

Treatment Protocols: While there is no cure for familial chondrocalcinosis, management focuses on alleviating symptoms and improving joint function. Treatment strategies include: - Use of nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Corticosteroid injections into affected joints for severe inflammation - Physical therapy to maintain joint flexibility and strength - Lifestyle modifications such as weight management and low-impact exercise - Applying heat or cold packs to ease discomfort - Possible use of medications to address underlying metabolic factors contributing to crystal formation In some cases, surgical interventions such as joint replacement may be considered if joint damage is severe.